The urogold100® utilizes the biological effects of Spark Waves® by stimulating the self-healing mechanism of the affected tissue on cellular and vascular level. In their study “Effects of low-energy shockwave therapy on the erectile function and tissue of a diabetic rat model” (2013) Qui et al were able to prove that Spark Waves® significantly ameliorate erectile dysfunction by promoting nerve regeneration, restoring endothelial and smooth muscle content as well as enhancing the recruitment of mesenchymal stem cells. The combination of all these factors significantly ameliorates erectile dysfunction as it leads to a long-term recovery of the erection function of patients and restores their sexual spontaneity as well as quality of life.
The shock wave therapy with urogold100® represents an effective and safe alternative to medication without the side effects of the latter and is even suitable for patients who do not respond to ingestive medical treatment. The treatment is carried out on an outpatient basis. Most importantly, the therapy is pain free and thus requires no anaesthesia. No side effects have been reported. urogold100® is equipped with a unique soft-wide focus applicator that ensures an even distribution of Spark Wave® energy for satisfying treatment results. The device is further characterized by its compact size and modern design that ensures easy transport and comfortable handling during treatment. Premium materials and the latest MTS technology guarantee high quality Spark Waves® for an ideal treatment process.
At a glance: - Innovative, safe and effective therapy for ED and other urogenital disorders - Unique biological Spark Wave® effects for successful therapy of urogenital disorders, such as ED - Safe alternative to ingestive medical treatment of ED without the side effects of the latter - Even suitable for ED-patients that did not respond to medication - High-quality MTS technology – tissue-friendly therapy
This device is not commercially available in the United States.
lithogold380 - The new device generation in ESWL for a gentle stone therapy
With lithogold380 MTS presents a new device generation for the tissue-friendly and efficient treatment of renal stones and other urological indications. The lithotripter is most notably characterized by its large focus (20 x 101 mm) and low energy highs (max. 36,9 MPa) which guarantees an especially effective and kidney- friendly therapy. The large system focus leads in >95% of all patients to the destruction of the stone with only one treatment and reduces the follow-up treatment rate. lithogold380 is especially suitable for the stone treatment of obese patients. In addition, the limited maximum pressure of the system guarantees a particularly tissue-friendly therapy reducing anaesthesia to a minimum.
At a glance: - High treatment success rate >95% with only 1 treatment - Reduced anesthesia requirements - Dual imaging with x-ray and ultrasound - Easy targeting with wide shockwave path - Especially suitable for stone treatment of obese patients - Deep penetration depth (165 mm) reduces the incidence of treating - patients in the prone position - Large focus zone (20 x 101 mm) & tip pressure of 36,9 MPa max. = kidney-friendly lithotripsy - Little side effects - Latest generation electrohydraulic (spark-gap) lithotripter
Indications in Urology: - Renal stones - Ureteral stones
In Orthopaedics: - Nonunion and delayed union fractures - Stress fractures - Avascular bone necrosis - Osteochondrosis dissecans - Greater trochanteric pain syndrome - Plantar fasciitis - Shoulder tendinopathies
orthogold100 - A multi-talented and premium quality device for orthopaedics
orthogold100 is an easily applicable and transportable therapy system. It is available with three different applicators and thus allows an efficient treatment of a very broad spectrum of orthopaedic shock wave indications ranging from heel spur to calcific tendinitis or myofascial trigger points.
Indications: - Shoulder tendinopathies with or without calcification - Epicondylopathia humeri radialis and ulnaris - Heel spur / Plantar fasciitis - Achillodynia - Jumper´s knee (patella tip syndrome) - Myofascial trigger points
Our medical device orthogold100 is characterized by its pure design, a modern system control via touchscreen and high-quality MTS technology. Furthermore, it features a low quantity of Spark WaveTM pulses per treatment session as well as a low follow-up treatment rate for satisfying treatment results.
At a glance: - Efficient – good treatment results with a low pulse & little total treatment rate - Effective – clinically proven - 3 applicators for the treatment of a broad spectrum of indications - High-quality MTS technology
orthogold280 - The effective alternative to surgery for pseudarthrosis
orthogold280 was specifically designed for the use in sports medicine, orthopedic and traumatological centers and is qualified for low and high-energy treatments for a growing number of orthopedic shock wave indications. Besides the treatment of orthopedic standard indications, orthogold280 is particularly suitable for the non-invasive therapy of pseudarthrosis.
Indications: - Pseudarthrosis (also in an infected stadium) - Shoulder impingement syndrome with or without calcification - Epicondylopathia humeri radialis and ulnaris - Hip necrosis - Heel spur / Plantar fasciitis - Achillodynia (painful inflammation of the Achilles’ tendon) - Jumper´s knee (patella tip syndrome)
Its treatment quality for bone treatment is manifested in its unique success rate of more than 81% with a singular treatment. The therapy itself is evidence based. Numerous scientific papers confirm the superiority of electro hydraulic based MTS patented Spark Wave therapy over surgery and other shock wave technologies.
Furthermore, bone treatment with orthogold280 significantly frees up OR time as well as personnel capacities for physicians and hospitals due to a shortened treatment session and drastically reduced requirements for OR-personnel. To patients concerned, treatment with orthogold280 offers a non-invasive treatment that leads to a shorter stay in hospital as well as a much faster recovery time compared to standard of care treatment.
At a glance: - Non-invasive therapy of pseudarthrosis – healing rate more than 81% with single treatment - Efficient – good treatment results with a low pulse & little total treatment rate - Effective – clinically proven - High-quality MTS technology
physiogold50 is based on the commonly used ballistic technology for the fast and economic therapy of numerous musculoskeletal disorders as well as treatment of cosmetic indications.
Indications: - Epicondylitis - Medial epicondylitis; - Insertional tendinitis - Impingement syndrome - Tendinopathy of the patellar tendon and pes anserinus - Adductor tendinopathy (pubic) - Tendinopathy of the Achille’s tendon - Calcaneal apophysis
The therapy system is a light-weight and handy medical device, ideal for mobile and home care use. It consists of a small main unit with integrated air compressor and features three applicator caps (9mm multi focused, 15mm multi focused, 15mm focused), especially for the treatment of indications with low penetration requirements. physiogold50 can be used intuitionally and easily operated via 8” LCD touch screen and saves up to 250 treatment protocols to simplify daily treatment process. Treatment with physiogold50 is further characterized by a minimum time required for treatments and healing as well as high success rate in patients.
physiogold50 may also be perfectly combined with MTS’ orthogold100. The combination of the high quality spark wave therapy systems with a ballistic source opens up an even wider indication spectrum for economic and efficient treatment results.
At a glance: - Light-weight & handy with integrated air compressor - Available with 3 applicator caps for treatment of broad indication range - Intuitive & easy to operate via 8’’ LCD touch screen - Saves up to 200 treatment protocols
Product category: Shock wave therapy equipment, Dressings for wounds
dermagold100 - The innovative therapy for diabetic foot ulcers
With dermagold100 MTS presents an innovative therapy option for the successful treatment of chronical, non-healing wounds such as diabetic foot ulcers for instance. The shock wave therapy system thereby makes use of the biological effects of Spark WavesTM so as to initiate the healing process in the affected region of the tissue and to stimulate the generation of new and healthy tissue.
In order to achieve optimal treatment results, an unfocused applicator was developed which exclusively releases unfocused Spark WaveTM energy onto the treatment area of the tissue. No anaesthesia is required for the treatment of chronic, non-healing lesions with dermagold100.
At a glance: - Innovative therapy for diabetic foot ulcers – clinically proven - Unique biological Spark WaveTM effects for successful wound healing - Efficient – good treatment results with a low pulse & little total treatment rate - High-quality MTS technology – tissue-friendly therapy
Presentation of the SparkWave therapy system urogold100
At the Medica 2016 we will present the new therapy system urogold100!
The innovative therapy system urogold100® provides a long-term effective and safe treatment for patients suffering from erectile dysfunction (ED), induratio penis plastica (IPP) and other urogenital indications.
urogold100® utilizes the biological effects of Spark Waves® to stimulate the self-healing of the affected tissue at cellular and vascular level. Spark Waves® encourage the formation of new blood vessels, the release of angiogenic growth factors and trigger – clinically proven – the migration of stem cells, which in turn increase blood circulation in the treated area significantly. The combination of all the mentioned factors leads to a long-term improvement in the erectile function and improves the sexual spontaneity and its associated quality of life of the patient.
urogold100® represents an effective and safe alternative to medical treatment of erectile dysfunction and it is also suitable for patients who have not responded to the medication.
For further information see the following link:
Let yourself be convinced by the Spark of Evidence!
MTS, located in Konstanz, Germany, is specialized in development, manufacture and distribution of a new generation of shock wave therapy systems that are successfully used worldwide in orthopedics, traumatology, wound care and urology. Our patented Spark Wave® technology guarantees the medically most effective shock waves, a consistently high treatment quality as well as excellent treatment results that are achieved with a low number of treatments required. For the development of innovative therapy methods we cooperate with internationally renowned universities and research institutions. The latest innovation is the successful treatment of erectile dysfunction. The product urogold100 promotes vascularization of the penis tissue and is an innovative long term treatment for patients with erectile dysfunction. Let yourself be convinced by our Spark Wave Therapy.